From Mendel to Medical Genetics: Milan Macek Jr. to Share Rare Disease Insights at ECTH 2025
European Congress on Thrombosis and Haemostasis (ECTH) posted on LinkedIn:
”From the legacy of Mendel to the frontlines of rare disease advocacy, Professor Milan Macek Jr., MD, DSc, is a true pioneer in medical genetics. As chair of the Czech Republic’s largest academic genetics centre and head of the National Coordination Centre for Rare Diseases, he’s shaping not just science, but national health strategies.
At ECTH 2025, Professor Milan Macek Jr. will take us on a journey through his session “From Mendel to medical genetics”, exploring how genetic breakthroughs are transforming diagnostics, care, and policy for rare diseases.
Expect a session that’s as visionary as it is practical; bridging history, cutting-edge research, and the real-world impact of coordinated action.
Join us at ECTH 2025.”
Stay updated with Hemostasis Today.
-
Apr 10, 2026, 01:19Heghine Khachatryan: When Vascular Fragility Defines Risk – Rethinking Hemostasis in LDS
-
Apr 9, 2026, 21:39Mechanisms of Immune Dysregulation in Immune Thrombocytopenia – JTH
-
Apr 9, 2026, 21:37Arun V J: The Nation Inside the Human Body and Blood Function
-
Apr 9, 2026, 21:36José Antonio García Erce: Fall of While Blood Donation And Apheresis Growth in Spain
-
Apr 9, 2026, 21:34Chokri Ben Lamine: High-Yield Clinical Insights on Carfilzomib-Induced aHUS
-
Apr 9, 2026, 21:29Satyam Arora: Improving Thalassaemia Care in India Through Ground-Level Data
-
Apr 9, 2026, 20:33Pat Garcia-Gonzalez: On World Health Day, I’m thinking about what ‘health’ really means.
-
Apr 9, 2026, 19:13Jan Sloves: Patterns and Pitfalls Influencing Treatment of Small Saphenous Vein Reflux
-
Apr 9, 2026, 18:38Jecko Thachil: Why D-dimers are Useful Tests for the Exclusion of Thromboembolism and the Diagnosis of DIC